Tehran University of Medical Sciences

Science Communicator Platform

Share By
Roles of Non-Coding Rnas in Cell Death Pathways Involved in the Treatment of Resistance and Recurrence of Cancer Publisher Pubmed



Motlagh FM1, 2 ; Kadkhoda S1 ; Motamedrad M3, 4 ; Javidzade P5 ; Khalilian S6, 7 ; Modarressi MH1 ; Ghafourifard S7
Authors

Source: Pathology Research and Practice Published:2023


Abstract

Considering the burden of cancer, a number of methods have been applied to control or stop it. However, because of drug resistance or cancer recurrence, these treatments usually face failure. Combination of modulation of expression of non-coding RNAs (ncRNAs) with other treatments can increase treatment-sensitivity of tumors but these approaches still face some challenges. Gathering information in this field is a prerequisite to find more efficient cures for cancer. Cancer cells use ncRNAs to enhance uncontrolled proliferation originated from inactivation of cell death routs. In this review article, the main routes of cell death and involved ncRNAs in these routes are discussed. Moreover, extant information in the role of different ncRNAs on cell death pathways involved in the treatment resistance and cancer recurrence is summarized. © 2023 Elsevier GmbH
Related Docs
View other Related Docs
1. The Multiplex Crosstalk Between Non-Coding Rnas, Programmed Cell Death and Related Mechanisms: A Dynamic Duo in Hematological Malignancies, Cancer Cell International (2025)
2. Non-Coding Rnas in Cancer Immunotherapy: A Solution to Overcome Immune Resistance?, Progress in Molecular Biology and Translational Science (2024)
3. Melatonin Targeting Non-Coding Rnas in Cancer: Focus on Mechanisms and Potential Therapeutic Targets, European Journal of Pharmacology (2023)
Experts (# of related papers)
View all Related Experts
Mohammad Shirkhoda (1)
Hamid Reza Mirzaei (1)
Other Related Docs
4. Role of Non-Coding Rnas in Neuroblastoma, Cancer Gene Therapy (2023)
5. The Role of Microrna-Induced Apoptosis in Diverse Radioresistant Cancers, Cellular Signalling (2023)
6. Piwi-Interacting Rnas: New Biomarkers for Diagnosis and Treatment of Breast Cancer, Cell and Bioscience (2020)
7. The Role of Non-Coding Rnas in the Regulation of Cell Death Pathways in Melanoma, Discover Oncology (2025)
8. Lncrnas Roles in Chemoresistance of Cancer Cells, Current Molecular Medicine (2022)
9. Deciphering the Role of Loc124905135-Related Non-Coding Rna Cluster in Human Cancers: A Comprehensive Review, Heliyon (2024)
10. Competing Endogenous Rnas Regulatory Crosstalk Networks: The Messages From the Rna World to Signaling Pathways Directing Cancer Stem Cell Development, Heliyon (2024)
11. Gene Therapy: A Promising Approach for Breast Cancer Treatment, Cell Biochemistry and Function (2022)
12. The Role of Natural Products As Inhibitors of Jak/Stat Signaling Pathways in Glioblastoma Treatment, Oxidative Medicine and Cellular Longevity (2022)
13. The Role of Long Noncoding Rnas (Lncrnas) in the Pathogenesis of Chemoresistance in Endometrial Cancer: A Molecular Approach and Future Perspective, Indian Journal of Gynecologic Oncology (2025)
14. Gynecologic Cancers and Non-Coding Rnas: Epigenetic Regulators With Emerging Roles, Critical Reviews in Oncology/Hematology (2021)
15. Biological Function and Molecular Mechanism of Pirna in Cancer, Practical Laboratory Medicine (2019)
16. Crosstalk Between Lncrnas in the Apoptotic Pathway and Therapeutic Targets in Cancer, Cytokine and Growth Factor Reviews (2022)
17. Non-Coding Rnas in Leukemia Drug Resistance: New Perspectives on Molecular Mechanisms and Signaling Pathways, Annals of Hematology (2024)
18. Targeted Cancer Therapy: Review Article, Tehran University Medical Journal (2018)
19. Non-Coding Rnas and Exosomal Non-Coding Rnas in Lung Cancer: Insights Into Their Functions, Frontiers in Cell and Developmental Biology (2024)
20. Recent Progress in the Immunotherapy of Hepatocellular Carcinoma: Non-Coding Rna-Based Immunotherapy May Improve the Outcome, Biomedicine and Pharmacotherapy (2023)